Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Cartesian Therapeutics (RNAC) Other Gross PP&E Adjustments (2016 - 2025)

Cartesian Therapeutics (RNAC) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with $8.7 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 53.88% to $8.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.7 million through Dec 2025, up 53.88% year-over-year, with the annual reading at $8.7 million for FY2025, 53.88% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $8.7 million at Cartesian Therapeutics, down from $11.5 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $11.5 million in Q3 2025, with the low at -$6.8 million in Q4 2021.
  • Average Other Gross PP&E Adjustments over 5 years is $310100.0, with a median of -$1.9 million recorded in 2022.
  • The sharpest move saw Other Gross PP&E Adjustments plummeted 104.48% in 2023, then surged 1024.5% in 2025.
  • Over 5 years, Other Gross PP&E Adjustments stood at -$6.8 million in 2021, then surged by 84.03% to -$1.1 million in 2022, then tumbled by 104.48% to -$2.2 million in 2023, then skyrocketed by 353.42% to $5.7 million in 2024, then surged by 53.88% to $8.7 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $8.7 million, $11.5 million, and $10.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.